Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
LX-2006 by Lexeo Therapeutics for Friedreich Ataxia: Likelihood of Approval
LX-2006 is under clinical development by Lexeo Therapeutics and currently in Phase II for Friedreich Ataxia. According to GlobalData, Phase...
LX-2006 by Lexeo Therapeutics for Cardiomyopathy: Likelihood of Approval
LX-2006 is under clinical development by Lexeo Therapeutics and currently in Phase II for Cardiomyopathy. According to GlobalData, Phase II...
LX-2006 by Lexeo Therapeutics for Cardiomyopathy: Likelihood of Approval
LX-2006 is under clinical development by Lexeo Therapeutics and currently in Phase II for Cardiomyopathy. According to GlobalData, Phase II...